Back to SHELTON CAPITAL MANAGEMENT SHELTON CAPITAL MANAGEMENT

UTHRUTHR

Showing 8 of 31 quarters

Position history for SHELTON CAPITAL MANAGEMENTSHELTON CAPITAL MANAGEMENT's holdings in UNITED THERAPEUTICS CORP DEL

Yes. Shelton Capital Management holds 1,394 shares of UTHR (United Therapeutics), worth $755,311, as of its Q2 2026 13F filing. It reduced the position by 27 shares (-1.9%) from Q1 2026. Shelton Capital Management has held UTHR in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$755,311

Current Shares

1,394

Total Value Change

+$136,799

Total Shares Change

-332

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1,394
-1.9%
$755,3110.0%$541.83
0
2026-Q1
Unchanged
1,421
0.0%
$842,6250.0%$592.98
0
2025-Q4
Decreased
1,421
-11.1%
$692,3820.0%$487.25
0
2025-Q3
Unchanged
1,599
0.0%
$670,3170.0%$419.21
0
2025-Q2
Decreased
1,599
-1.5%
$459,4730.0%$287.35
0
2025-Q1
Decreased
1,624
-3.3%
$500,6300.0%$308.27
0
2024-Q4
Decreased
1,679
-2.7%
$592,4180.0%$352.84
0
2024-Q3
Unchanged
1,726
0.0%
$618,5120.0%$358.35
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used